Internal Medicine, Endocrinology, Diabetes, & Metabolism · Langhorne, PA
NPI
1548263544
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
380 Middletown Blvd, Ste 710
Langhorne, PA, 19047
Phone (215) 750-1691
Groups this clinician bills Medicare through
Medicare paid, 2024
$113K
1,599 services
Medicare patients, 2024
566
Average age 72
Drug cost, 2024
$2.2M
4,463 prescriptions
Company payments, 2025
$5,911
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alan B Schorr was code 99214 (office e&m - established), 926 times for 498 patients. In total Alan B Schorr billed 1,599 services in 10 codes, and Medicare paid $113K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-01-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 926 | 498 | $90.29 | $84K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 361 | 349 | $13.37 | $4,828 |
| 95251 Test - Miscellaneous | Office | 184 | 95 | $25.69 | $4,727 |
| 99205 Office E&M - New | Office | 95 | 95 | $165.21 | $16K |
| 99215 Office E&M - Established | Office | 27 | 26 | $134.58 | $3,634 |
By year: 2022 $169K for 1,880 services; 2023 $107K for 1,180 services; 2024 $113K for 1,599 services.
Medicare prescription drug claims, 2024
In 2024, the drug Alan B Schorr prescribed most often to Medicare patients was Levothyroxine Sodium, with 647 prescriptions and refills. In total Alan B Schorr wrote 4,463 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 647 | 1,713 | 185 | $8,853 |
| Synthroid Levothyroxine Sodium | 339 | 952 | 101 | $38K |
| Metformin Hcl Generic | 262 | 723 | 81 | $2,214 |
| Repaglinide Generic | 230 | 601 | 76 | $14K |
| Trulicity Dulaglutide | 204 | 351 | 52 | $336K |
| Mounjaro Tirzepatide | 187 | 329 | 44 | $347K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 167 | 394 | 61 | $25K |
| Nateglinide Generic | 141 | 411 | 59 | $17K |
| Jardiance Empagliflozin | 138 | 317 | 33 | $176K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 135 | 361 | 56 | $17K |
| Glimepiride Generic | 93 | 266 | 32 | $1,342 |
| Ozempic Semaglutide | 88 | 159 | 22 | $136K |
| Novolog Flexpen Insulin Aspart | 83 | 180 | 33 | $26K |
| Tresiba Flextouch U-200 Insulin Degludec | 77 | 181 | 22 | $90K |
| Liothyronine Sodium Generic | 74 | 200 | 25 | $3,111 |
Brand drugs: 2,224 claims; generic drugs: 1,934 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alan B Schorr $5,911 ($1,186 in general payments such as food, travel and fees and $4,725 for research) from 4 companies. The largest payer was Medtronic, Inc. with $5,850.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.